These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22661240)

  • 1. Spontaneous rectovaginal fistula during bevacizumab therapy for colon cancer.
    Bernal-Sprekelsen JC; Landete FJ; Safont MJ; López J
    Int J Colorectal Dis; 2013 Apr; 28(4):591. PubMed ID: 22661240
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous rectovaginal fistula during bevacizumab therapy for ovarian cancer: a case report.
    Chéreau E; Stefanescu D; Selle F; Rouzier R; Daraï E
    Am J Obstet Gynecol; 2009 Jan; 200(1):e15-6. PubMed ID: 19121652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed rectovaginal fistula: a potential complication of bevacizumab (avastin).
    Ley EJ; Vukasin P; Kaiser AM; Ault G; Beart RW
    Dis Colon Rectum; 2007 Jun; 50(6):930. PubMed ID: 17429706
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of delayed colonic perforation after metallic stent placement for advanced descending colon cancer during bevacizumab-based chemotherapy].
    Tanaka I; Hisai H; Miyazaki E; Ono M; Maeda Y; Sato M; Kawasaki R; Gyobu H; Nakajima S; Yamada S; Muramatsu H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2319-21. PubMed ID: 22202368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy.
    August DA; Serrano D; Poplin E
    J Surg Oncol; 2008 Feb; 97(2):180-5. PubMed ID: 18095268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and radiological response with FOLFOXIRI and bevacizumab as third-line therapy after mFOLFOX6 and FOLFIRI failure.
    de Melo JV; Vieira de Melo MS; Abad MH
    Anticancer Drugs; 2011 Jun; 22 Suppl 2():S19-20. PubMed ID: 21768793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab-associated fistula formation in postoperative colorectal cancer patients.
    Ganapathi AM; Westmoreland T; Tyler D; Mantyh CR
    J Am Coll Surg; 2012 Apr; 214(4):582-8; discussion 588-90. PubMed ID: 22321523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diaphragmatic rupture, a new complication of Bevacizumab.
    Lacaze L; Scotté M
    Eur J Surg Oncol; 2012 Nov; 38(11):1079-81. PubMed ID: 22818843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proctomucosectomy and colo-anal anastomosis in rectovaginal fistula following the use of suppositories containing ergotamine].
    Schwab A; Werthmann K; Merkle P; Thiele HH
    Chirurg; 1988 Jun; 59(6):432-4. PubMed ID: 3144448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete remission of psoriasis following bevacizumab therapy for colon cancer.
    Akman A; Yilmaz E; Mutlu H; Ozdogan M
    Clin Exp Dermatol; 2009 Jul; 34(5):e202-4. PubMed ID: 19077094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive fungal infection and nasal septum perforation with bevacizumab-based therapy in advanced colon cancer.
    Ruiz N; Fernandez-Martos C; Romero I; Pla A; Maiquez J; Calatrava A; Guillem V
    J Clin Oncol; 2007 Aug; 25(22):3376-7. PubMed ID: 17664487
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer.
    Mutlu H; Berk V; Karaca H; Erden A; Aslan T; Akca Z
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):546-8. PubMed ID: 22203035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [mFOLFOX6 and FOLFIRI/bevacizumab treatment in a patient on hemodialysis with metastatic colon cancer].
    Kuwabara H; Baba H; Wakabayashi M; Nakamura H; Sanada T; Baba H; Nakajima K; Goseki N
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2250-2. PubMed ID: 22202345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer.
    Stevenson JP; Langer CJ; Somer RA; Evans TL; Rajagopalan K; Krieger K; Jacobs-Small M; Dyanick N; Milcarek B; Coakley S; Walker S; Eaby-Sandy B; Hageboutros A
    Cancer; 2012 Nov; 118(22):5580-7. PubMed ID: 22544579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicorandil-induced rectovaginal fistula.
    Neely DT; Minford EJ
    Am J Obstet Gynecol; 2011 Apr; 204(4):e5-6. PubMed ID: 21306699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the long-term pharmacokinetics of bevacizumab following last dose in patients with resected stage II and III carcinoma of the colon.
    Li J; Gupta M; Jin D; Xin Y; Visich J; Allison DE
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):575-80. PubMed ID: 23228985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do targeted agents not work in the adjuvant setting in colon cancer?
    Oyan B
    Expert Rev Anticancer Ther; 2012 Oct; 12(10):1337-45. PubMed ID: 23176621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion treatment of hepatic metastases of colon adenocarcinoma by bevacizumab and FOLFOX.
    Leite D; Kater FR
    Anticancer Drugs; 2011 Jun; 22 Suppl 2():S1-7. PubMed ID: 21768791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade.
    Esfahani K; Miller WH
    N Engl J Med; 2017 May; 376(20):1989-91. PubMed ID: 28514612
    [No Abstract]   [Full Text] [Related]  

  • 20. Vulvar mucinous adenocarcinoma associated with Crohn's disease: report of two cases.
    Matsuo K; Chi DS; Eno ML; Im DD; Rosenshein NB
    Gynecol Obstet Invest; 2009; 68(4):276-8. PubMed ID: 19828998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.